Effect of methylprednisolone in patients with Guillain-Barré syndrome.
Susuki
Keiichiro
K
Yuki
Nobuhiro
N
D001323:Autoantibodies / Q000032:analysis; D004359:Drug Therapy, Combination; D005677:G(M1) Ganglioside / Q000276:immunology; D005938:Glucocorticoids / Q000008:administration & dosage*; D020275:Guillain-Barre Syndrome / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage*; D008775:Methylprednisolone / Q000008:administration & dosage*
D001323:Autoantibodies; D005938:Glucocorticoids; D016756:Immunoglobulins, Intravenous; D005677:G(M1) Ganglioside; D008775:Methylprednisolone